 | Up a level |
Munster, Pamela N., Mahipal, Amit, Nemunaitis, John J., Mita, Monica M., Paz-Ares, Luis G., Massard, Christophe, Mikkelsen, Tom, Cruz, Cristina, Rathkopf, Dana E., Blumenschein, George R., Hidalgo, Manuel, Smith, David C., Eichhorst, Barbara, Cloughesy, Timothy Francis, Garrick, Brett, Trowe, Torsten, Filvaroff, Ellen, Hege, Kristen and Bendell, Johanna C. (2016). Phase I trial of a dual TOR kinase and DNA-PK inhibitor (CC-115) in advanced solid and hematologic cancers. J. Clin. Oncol., 34 (15). ALEXANDRIA: AMER SOC CLINICAL ONCOLOGY. ISSN 1527-7755
Thijssen, Rachel 
ORCID: 0000-0002-4493-306X, ter Burg, Johanna, Garrick, Brett, van Bochove, Gregor G. W., Brown, Jennifer R., Fernandes, Stacey M., Sole Rodriguez, Maria, Michot, Jean-Marie ORCID: 0000-0003-3482-3331, Hallek, Michael, Eichhorst, Barbara, Reinhardt, Hans Christian, Bendell, Johanna, Derks, Ingrid A. M., van Kampen, Roel J. W., Hege, Kristen, Kersten, Marie Jose, Trowe, Torsten, Filvaroff, Ellen H., Eldering, Eric and Kater, Arnon P.
(2016).
Dual TORK/DNA-PK inhibition blocks critical signaling pathways in chronic lymphocytic leukemia.
Blood, 128 (4).
S. 574 - 584.
WASHINGTON:
AMER SOC HEMATOLOGY.
ISSN 1528-0020